These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24850810)

  • 1. Soluble vascular adhesion protein-1 predicts incident major adverse cardiovascular events and improves reclassification in a finnish prospective cohort study.
    Aalto K; Havulinna AS; Jalkanen S; Salomaa V; Salmi M
    Circ Cardiovasc Genet; 2014 Aug; 7(4):529-35. PubMed ID: 24850810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations.
    Aalto K; Maksimow M; Juonala M; Viikari J; Jula A; Kähönen M; Jalkanen S; Raitakari OT; Salmi M
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):523-32. PubMed ID: 22116093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 Cohort.
    Havulinna AS; Sysi-Aho M; Hilvo M; Kauhanen D; Hurme R; Ekroos K; Salomaa V; Laaksonen R
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2424-2430. PubMed ID: 27765765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-, sex- and glucose-dependent correlation of plasma soluble vascular adhesion protein-1 concentration with cardiovascular risk factors and subclinical atherosclerosis.
    Chen DW; Jin Y; Zhao RM; Long LJ; Zhang J; Han CL; Roivainen A; Knuuti J; Jalkanen S; Wang JC
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1544-58. PubMed ID: 27160127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes.
    Salmi M; Stolen C; Jousilahti P; Yegutkin GG; Tapanainen P; Janatuinen T; Knip M; Jalkanen S; Salomaa V
    Am J Pathol; 2002 Dec; 161(6):2255-62. PubMed ID: 12466139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between serum HDL-cholesterol, cardiovascular disease and mortality in community-based people with type 2 diabetes: the Fremantle Diabetes Study phase 2.
    Davis TME; Chubb SAP; Davis WA
    Cardiovasc Diabetol; 2024 Oct; 23(1):362. PubMed ID: 39402659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vascular adhesion protein-1 is up-regulated in hyperglycemia and is associated with incident diabetes negatively.
    Kuo CH; Wei JN; Yang CY; Ou HY; Wu HT; Fan KC; Wang SH; Hua CH; Hsiao CH; Lee MK; Li HY
    Int J Obes (Lond); 2019 Mar; 43(3):512-522. PubMed ID: 30022055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
    Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
    J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.
    Würtz P; Havulinna AS; Soininen P; Tynkkynen T; Prieto-Merino D; Tillin T; Ghorbani A; Artati A; Wang Q; Tiainen M; Kangas AJ; Kettunen J; Kaikkonen J; Mikkilä V; Jula A; Kähönen M; Lehtimäki T; Lawlor DA; Gaunt TR; Hughes AD; Sattar N; Illig T; Adamski J; Wang TJ; Perola M; Ripatti S; Vasan RS; Raitakari OT; Gerszten RE; Casas JP; Chaturvedi N; Ala-Korpela M; Salomaa V
    Circulation; 2015 Mar; 131(9):774-85. PubMed ID: 25573147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple cardiovascular risk stratification by replacing total serum cholesterol with anthropometric measures: The MORGAM prospective cohort project.
    Rosberg V; Vishram-Nielsen JK; Kristensen AMD; Pareek M; Sehested TSG; Nilsson PM; Linneberg A; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Veronesi G; Grassi G; Kuulasmaa K; Salomaa V; Palosaari T; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Moitry M; Drygas W; Tamosiunas A; Peters A; Brenner H; Schöttker B; Grimsgaard S; Biering-Sørensen T; Olsen MH
    Prev Med Rep; 2022 Apr; 26():101700. PubMed ID: 35141116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma soluble vascular adhesion protein-1 concentration correlates with arterial stiffness: A cross-sectional study.
    Chen DW; Zhao RM; Jin Y; Zhang J; Han C; Jiang SQ; Zheng HF; Wang JC
    Arch Gerontol Geriatr; 2015; 61(1):67-71. PubMed ID: 25959807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.
    Yeboah J; Folsom AR; Burke GL; Johnson C; Polak JF; Post W; Lima JA; Crouse JR; Herrington DM
    Circulation; 2009 Aug; 120(6):502-9. PubMed ID: 19635967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
    Yoshikawa N; Noda K; Shinoda H; Uchida A; Ozawa Y; Tsubota K; Mashima Y; Ishida S
    J Diabetes Complications; 2013; 27(2):162-6. PubMed ID: 23062326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
    Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
    Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma total testosterone and incident cardiovascular events in hypertensive patients.
    Vlachopoulos C; Ioakeimidis N; Terentes-Printzios D; Aznaouridis K; Rokkas K; Aggelis A; Synodinos A; Lazaros G; Stefanadis C
    Am J Hypertens; 2013 Mar; 26(3):373-81. PubMed ID: 23382488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes.
    Li HY; Jiang YD; Chang TJ; Wei JN; Lin MS; Lin CH; Chiang FT; Shih SR; Hung CS; Hua CH; Smith DJ; Vanio J; Chuang LM
    Diabetes; 2011 Mar; 60(3):993-9. PubMed ID: 21282368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.
    Gurecká R; Koborová I; Csongová M; Šebek J; Šebeková K
    Glycoconj J; 2016 Aug; 33(4):599-606. PubMed ID: 27300745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three troponins as predictors of future cardiovascular events--prospective results from the FINRISK and BiomaCaRE studies.
    Neumann JT; Havulinna AS; Zeller T; Appelbaum S; Kunnas T; Nikkari S; Jousilahti P; Blankenberg S; Sydow K; Salomaa V
    PLoS One; 2014; 9(3):e90063. PubMed ID: 24594734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Vardas E; Dimoulios P; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):405-8. PubMed ID: 11943954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study).
    McCarthy CP; van Kimmenade RRJ; Gaggin HK; Simon ML; Ibrahim NE; Gandhi P; Kelly N; Motiwala SR; Belcher AM; Harisiades J; Magaret CA; Rhyne RF; Januzzi JL
    Am J Cardiol; 2017 Jul; 120(1):25-32. PubMed ID: 28487034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.